Tuberculosis: New Drug Discovery Pipelines
Journal: Austin Journal of Analytical and Pharmaceutical Chemistry (Vol.1, No. 3)Publication Date: 2014-08-23
Authors : Arya N; Raut MK; Tekale SG; Shishoo CJ; Jain KS;
Page : 1-9
Keywords : Tuberculosis; Multi drug- resistant tuberculosis (MDR- TB); Extensively drug-resistant tuberculosis (XDR-TB); New drug discovery pipelines;
Abstract
The resurgence of tuberculosis from a forgotten disease to a modern and resurgent pathology is a matter of serious global concern. Development and transmission of Multi Drug- Resistant (MDR) and extensively drug-resistant (XDR) tuberculosis is an important public health problem worldwide. This review covers mainly the therapeutic limitations to treat these resistant disease forms, as well as, the current status of drug discovery and development for anti-tubercular therapy and treatment.
Other Latest Articles
- “Zero-Crossing” First-order Derivative Spectroscopy Method for Analysis of Sertraline Hydrochloride in Novel Self Micro Emulsifying Drug Delivery System
- Separation and Determination of Prochlorperazine Maleate and Pyridoxine Hydrochloride in Tablet Formulation by RP-HPLC
- Development of Hemosomal Drug Delivery System
- Automatic Backup System for Virtualization Environment
- Impression Generation of Indonesian Cultural Paintings for Mobile Application with Culture Dependent Color-Impression Metric Creation Contents
Last modified: 2016-06-21 18:25:02